Rima Senvest Management Discloses Increase In Radware Ltd (RDWR) Stake

Richard Mashaal is bullish on Radware Ltd. (NASDAQ:RDWR) and has recently increased his fund’s stake in the company. According to a recent filing with the Securities and Exchange Commission, Mashaal’s fund, Rima Senvest Management has increased its stake by some 311,900 shares, taking it to 4.43 million shares, which account for 9.6% of the total number of shares outstanding.

Radware Ltd. (NASDAQ:RDWR)

Many of the hedge fund gurus that we track don’t seem to share Mashaal’s enthusiasm for Radware Ltd. (NASDAQ:RDWR), having limited their exposure during the last quarter of 2013. James Dinan and his fund, York Capital Management, have reduced their stake by 26% to approximately 823,600 shares reportedly worth $14.8 million. D. E. Shaw‘s adjustment was not so drastic, having reduced his investment by 12%. In its latest 13F filing, D E Shaw reported ownership of 577,300 shares valued at $10.3 million.

A provider of integrated networking solutions, Radware Ltd. (NASDAQ:RDWR) has a market cap of $745 million and does not pay a dividend. The stock is traded at a trailing Price to Earnings (P/E) ratio of 43.xx, significantly higher than the industry average of 16.40. So far this year, it has been trending sideways, sliding 6.6% to a current price of $16.8 per share. The company announced revenues of $53 million, up 6.4% year-over-year, and earnings of $0.12 per share for the three months ending December 31, 2013. Analysts expect Radware to post $50 million in revenues and earnings of $0.17 per share for the first quarter of 2014.

During the fourth quarter of 2013, Mashaal has made some important changes to his fund’s equity portfolio, a notable move being the increase in its holding of CEVA, Inc. (NASDAQ:CEVA) stock by 19%. Rima Senvest reported ownership of 2.6 million shares valued at $39.6 million in its latest 13F filing. Mashaal is also a fan of Apple Inc. (NASDAQ:AAPL) and has increased his stake in the company by 39% during the same period of time, taking it to 64,613 worth approximately $36.2 million. David Einhorn and Carl Icahn are known fans of Apple and hold significant stakes in the tech giant.

Disclosure: none.

Recommended reading:

Nelson Obus, Wynnefield Capital Boost Stake In Nature’s Sunshine Prod. (NATR)

Bill Ackman’s Pershing Square Further Cuts Position In BEAM Inc (BEAM)

Deerfield Management Reveals Position in Newly Public Company Trivascular Technologies Inc (TRIV)

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!